This acquisition raises urgent questions about pharmaceutical companies prioritizing profits over public health. When B…

This acquisition raises urgent questions about pharmaceutical companies prioritizing profits over public health. When Big Pharma merges with cancer treatment firms, who decides what treatments are accessible? We need transparency about how drug pricing will be affected and whether these mergers actually advance patient care or just enrich shareholders at the expense of global health equity. *197 characters*